Sort
34,240 grants matching “atherosclerosis”
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin
$350,110David G Harrison · Vanderbilt University · P01 · FY2014 · GM
C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
$350,092John Patterson Atkinson · Washington University · R01 · FY2013 · AI
Pericardial fat and subclinical and clinical measures of coronary heart disease
$350,084Jingzhong Ding · Wake Forest University Health Sciences · R01 · FY2009 · HL
Confocal Microscope Core for Translational Research
$350,032Sigrid C Veasey · University Of Pennsylvania · S10 · FY2009 · RR
Oxidative lipid stress in the brain
$350,000Paul H. Axelsen · University Of Pennsylvania · R01 · FY2015 · NS
Validate 2: Vascular Aging: The Link That Bridges Age to Atherosclerosis
$350,000Johns Hopkins University · N01 · FY2012 · AG
Oxidative lipid stress in the brain
$350,000Paul H. Axelsen · University Of Pennsylvania · R01 · FY2012 · NS
Oxidative lipid stress in the brain
$350,000Paul H. Axelsen · University Of Pennsylvania · R01 · FY2011 · NS
Activator-Targeted Subunits of the ARC/Mediator
$350,000Massachusetts General Hospital · R01 · FY2005 · GM
Endothelial Dysfunction in Postischemic Hearts
$350,000Yong Xia · Ohio State University · R01 · FY2007 · HL
Genetic Mechanisms of Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
$349,997Steven Edward Lipshultz · University Of Miami School Of Medicine · R01 · FY2007 · CA
Complement, Cardiovascular Disease, and SLE
$349,918University Of Pittsburgh At Pittsburgh · R01 · FY2003 · AR
Selectivity and Permeation in the Human Voltage-gated Proton Channel, hHv1
$349,911Thomas E Decoursey · Rush University Medical Center · R01 · FY2013 · GM
OPTICAL CONTROL OF SINGLE CELL BEHAVIOR
$349,911Narasimhan Gautam · Washington University · R01 · FY2014 · GM
TGF-beta in intimal hyperplasia after vascular bypass
$349,896K Craig Kent · University Of Wisconsin-Madison · R01 · FY2013 · HL
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2021 · ES
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2022 · ES
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2020 · ES
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
$349,875Dana Dabelea · University Of Colorado Denver · U01 · FY2016 · DK
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study
$349,851Emelia J. Benjamin · Boston University Medical Campus · R01 · FY2009 · AG
Uncoupling of IL-1 beta and VEGF-A Crosstalk Contributes to Impaired Arteriogenesis Response to Ischemia in Chronic Diabetes Mellitus
$349,847Chris S Mantsounga · Ocean State Research Institute, Inc. · P20 · FY2022 · GM
Phosphorylation and Endothelial Nitric Oxide Production
$349,813William C. Sessa · Yale University · R01 · FY2007 · HL
Cellular senescence in aging and age-related disease.
$349,800Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2019 · AG
Cellular senescence in aging and age-related disease.
$349,800Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2018 · AG
Cellular senescence in aging and age-related disease.
$349,800Richard J Bram · Mayo Clinic Rochester · R01 · FY2022 · AG